Shilpa Medicare Recalls Imatinib Mesylate Tablets Due to Manufacturing Deviations
Shilpa Medicare Limited is voluntarily recalling 2,611 bottles of Imatinib Mesylate 100 mg tablets due to Current Good Manufacturing Practice (CGMP) deviations.
- Product
- IMATINIB MESYLATE — IMATINIB MESYLATE (IMATINIB MESYLATE)
- Category
- Drug
- Distribution
- Distributed nationwide